Popovits Kimberly J

Popovits Kimberly J is listed in filings as Director at 10x Genomics, Inc.. This profile follows SEC Form 4 activity through Jun 8, 2026, including 9 public disclosures. Recent filings connect the profile to 10x Genomics, Inc. (TXG), Rhythm Pharmaceuticals, Inc. (RYTM), and Exact Sciences Corporation (EXAS). The current snapshot covers public activity from Jun 13, 2024 to Jun 8, 2026. Reported amounts are shown as $903.8K to $67. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.